Context Therapeutics (CNTX) executive compensation, 2026 proxy

Martin Lehr, Chief Executive Officer, was paid $1.5M in 2025, up 45% from $1M the year before.

Filed
April 28, 2026
Annual meeting
June 24, 2026
Pay year
2025
Named executives
3
CEO total pay
$1.5M+45% vs prior year
CEO 2025 Total Pay
$1,465,430Increased from prior year
CEO Target Bonus %
50%Increased to 55% for 2026
Bonus Payout %
105%Includes 100% achievement plus 5% discretionary
CEO Option Awards
$551,415Grant date fair value

How Lehr was paid

$1.5M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary40%Bonus1%Option awards38%Non-equity incentive20%All other compensation1%

Named executive officers

ExecutiveTotal
Martin LehrChief Executive Officer$1,465,430
Alex LevitChief Legal Officer and Corporate Secretary$816,671
Jennifer Minai-AzaryChief Financial Officer and Treasurer$866,139

What changed and why

  • $1.5MMartin Lehr received total compensation of $1,465,430 in 2025, representing an increase from $1,011,069 in 2024.
  • 100%The 2025 annual bonus plan performance goals were achieved at a 100% level.
  • 5%Named executive officers were granted an additional discretionary bonus equal to 5% of target.
  • $635KMartin Lehr's base salary was increased to $635,000 effective February 16, 2026.
  • 55%Martin Lehr's target bonus percentage was increased to 55% for the 2026 fiscal year.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.